科研之友
微信
新浪微博
Facebook
分享链接
摘要
In this issue of Blood, Basiorka et al have challenged how we think about cell death in myelodysplastic syndromes (MDS), proposed an explanation for the shared morphologic changes that are seen despite genetic heterogeneity, and identified a new target for therapeutic intervention.(1)
- 出版日期2016-12-22
